June 17, 2024

NAMI Ask the Expert: A Research Update on Psychedelic Mental Health Treatments Thursday, July 25, 2024 | 4 - 5:30 p.m. ET

Thursday, July 25, 2024 | 4 – 5:30 p.m. ET

How does using psychedelics impact the brain? Does new research indicate that psychedelics could become part of some individuals’ mental health treatments?

Get the answers to these questions in our next Ask the Expert webinar! Register today and learn about the most up-to-date research on using psychedelics to treat mental illness. Throughout the discussion, our guest expert, Dr. Dimitri Perivoliotis, will share reflections from his own clinical work and firsthand experiences.

This Ask the Expert session will:

  • Help attendees understand the role of recovery-oriented care in psychedelic treatment
  • Provide recommendations to people pursuing this type of treatment
  • Describe challenges and open questions in the field of psychedelic treatment research

Reserve your spot to hear from Dr. Dimitri Perivoliotis. For over twenty years Dr. Perivoliotis has been involved in mental health treatment and research, focusing on innovative applications of evidence-based psychotherapy.

We welcome your participation and invite you to submit questions for our guest expert through the webinar registration form.

Register Now

Our Guest Expert

Dimitri Perivoliotis, Ph.D.Dimitri Perivoliotis, Ph.D.
Psychologist, VA San Diego Healthcare System – Neuromodulation Program
Clinical Professor, UCSD School of Medicine Dept. of Psychiatry

Dr. Perivoliotis has been involved in mental health treatment and research for over 20 years, with a focus on developing innovative applications of evidence-based psychotherapy for improving functioning and quality of life in people with serious mental illness (SMI). He currently is a staff psychologist at the VA San Diego Healthcare System and Clinical Professor of Psychiatry at the UCSD School of Medicine. His primary research and clinical interest is psychedelic-assisted therapy. He oversees the design and implementation of ketamine-assisted psychotherapy and other psychotherapeutic services at the VA San Diego Neuromodulation Program, a recovery-oriented clinic for Veterans with treatment-resistant depression and PTSD. Dr. Perivoliotis is a co-investigator and study therapist on a pilot study of MDMA-assisted brief cognitive behavioral conjoint therapy for Veterans with PTSD and their partners, the first of its kind at the VA San Diego (principal investigator: Dr. Leslie Morland). Previously, he served as Lead US Adherence Rater for the Lykos Therapeutics (formerly Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation) Phase III clinical trials of MDMA-assisted therapy for PTSD. He also managed an award-winning psychosis clinic and psychosis training program at the VA San Diego. Along with Dr. Aaron T. Beck and colleagues at the University of Pennsylvania, he co-developed a promising new approach to cognitive therapy for promoting recovery in people with SMI and co-authored the book, Recovery-Oriented Cognitive Therapy for Serious Mental Health Conditions.

NAMI HelpLine is available M-F, 10 a.m. – 10 p.m. ET. Call 800-950-6264,
text “helpline” to 62640, or chat online. In a crisis, call or text 988 (24/7).